Detalhe da pesquisa
1.
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness.
Cytotherapy
; 25(7): 750-762, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086241